POLYETHYLENE GLYCOL 4000

Unresolved Excipient

Suggest One No specific molecular structure known for this excipient.
CAS
25322683
UNII
4R4HFI6D95
SYNONYMS
ZINC ID(s)
Availability
Present in 0 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Analogs cannot be located as there is no structure provided for this compound. Try a search by name.

Dosages

Route Formulation Per Unit Dose
Auricular (otic) Suspension
Dental Ointment
Intra-Articular Injection 3%
Intralesional Injection 3%
Intramuscular Injection 3%
Intramuscular Suspension 3%
Intramuscular Suspension, Extended Release 7.5%
Intramuscular Suspension, Injection 4.5%W/V
Intrasynovial Injection 3%
Intravenous Injection, Suspension 0.49%
Ophthalmic Suspension
Oral Capsule 380.5MG
Oral Capsule, Delayed Action 2.55MG
Oral Capsule, Enteric Coated Pellets 96.19MG
Oral Capsule, Extended Release 10.72MG
Oral Capsule, Soft Gelatin 15MG
Oral Solution 42.75%
Oral Tablet 15MG
Oral Tablet (immed./comp. Release), Film Coated 1.5MG
Oral Tablet, Coated 2MG
Oral Tablet, Delayed Action 1MG
Oral Tablet, Delayed Action, Enteric Coated 0.96MG
Oral Tablet, Extended Release 45MG
Oral Tablet, Film Coated 4.2MG
Oral Tablet, Multilayer, Extended Release 2.8MG
Oral Tablet, Sustained Action 454MG
Oral Tablet, Sustained Action, Film Coated 1.8MG
Rectal Suppository 1269MG
Soft Tissue Injection
Sublingual Tablet 2.5MG
Topical Emulsion, Cream
Topical Ointment 84%
Topical Solution
Vaginal Emulsion, Cream 0.5%
Vaginal Suppository

More Information

Usage Over Time

Comments